Merck: Navigating Patent Cliff and Growth Prospects
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Understand the compelling reasons to get a no annual fee travel card. Enjoy perks without the extra charges.
26,540 articlesMerck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
A massive compute deal rumor could redraw the AI cloud map. This article explains what the potential billion compute ...
SoundHound AI is testing a high-growth path in voice commerce and Vision AI. This article explains why some investors...
Lulu's LVLU is shaping its 2026 earnings story through stronger direct channels, smarter pricing, and inventory disci...
Institutional appetite for BTC is reshaping retirement planning. Analysts say a measured, long-term approach could me...
Retirees are increasingly adopting a bucket-style retirement income strategy to cushion withdrawals from market downt...
SpaceX sits at the edge of a dramatic valuation leap. This article explores a pivotal contract, the math behind a pos...
Meta’s latest quarter hints at more than just headline growth. This article explains why some investors excited about...
Stock splits can make a popular stock feel more approachable, but they don’t change the business. Read on to see how ...
MP Materials has grabbed attention near the $60 level after high-profile partnerships. This guide breaks down whether...
Mind tech (mind) 2027 is shaping a new era for investors who seek durable growth in neurotech and digital mental heal...
Could Monero surpass Cardano by 2028? This article lays out the pathways, risks, and strategies for investors trackin...